|
May 22
|
Hims & Hers Is Selling Copycat Weight-Loss Drugs. Here’s How.
|
|
May 22
|
Australia Bans Replica Versions Of Popular Weight-Loss Drugs From Novo Nordisk, Eli Lilly On Safety Concerns
|
|
May 22
|
Novo Nordisk Once-Weekly Insulin Icodec Poses Hypoglycemia Risk, FDA Says
|
|
May 22
|
Top Research Reports for Novo Nordisk, QUALCOMM & Caterpillar
|
|
May 22
|
Play These New ETFs to Tap Lucrative Weight Loss Drug Market
|
|
May 21
|
Eli Lilly's diabetes drug tirzepatide gets approval in China
|
|
May 20
|
Hims & Hers Health to Offer GLP-1 Weight Loss Injections; Stock Soars
|
|
May 20
|
Hims & Hers Stock Spikes. It’s Taking on Big Pharma With Cheap Obesity Shots.
|
|
May 20
|
Genetic Profile Key To Novo Nordisk's Wegovy's Weight-Loss Effectiveness, Study Reveals
|
|
May 20
|
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen
|
|
May 18
|
Microsoft Leads Five Stocks Near Buy Points As Market Flashes Green
|
|
May 18
|
3 Monster Stocks in the Making You Can Buy Right Now
|
|
May 18
|
Is Novo Nordisk Stock a Millionaire Maker?
|
|
May 15
|
Novo Nordisk Weigh-Loss Drugs Could Bankrupt US Health Care, Senate Committee Report Says
|
|
May 15
|
No Wegovy Shortage in Denmark Amid High Demand, Novo Nordisk Confirms
|
|
May 15
|
Eli Lilly Strikes Deal To Combat Counterfeit Diabetes And Weight Loss Drugs Mounjaro And Zepbound
|
|
May 15
|
Should You Hold Viking Therapeutics (VKTX) in Your Portfolio?
|
|
May 15
|
If You'd Invested $1,000 in Novo Nordisk Stock 5 Years Ago, Here's How Much You'd Have Today
|
|
May 15
|
Here's Why Novo Nordisk (NVO) is a Strong Momentum Stock
|
|
May 15
|
Novo Holdings buys stake in life sciences tools company; BioMarin lays off 170
|